Daneng Li, M.D., a City of Hope associate professor in the Department of Medical Oncology & Therapeutics Research commented:
“The results show that our novel oncolytic virus — both alone or in combination with immunotherapy — has the ability to control various cancer types previously resistant to other treatment options, and these early results provide patients with hope of a new treatment option for cancers refractory to standard treatment.”
GLTAH
Ann: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting, page-5
-
- There are more pages in this discussion • 300 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
